| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| CHINA YONGXIN PHARMACEUTICALS Aktie jetzt für 0€ handeln |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| IONIS PHARMACEUTICALS | 25,690 | +1,66 % | Ihre wichtigsten Termine: Frische Q-Zahlen von: Hannover Rück, Zeta Global, Ionis, NRG, monday.com und Plug Power | © Foto: Raphael Knipping/dpaGut geplant in den Tag. Mit dem wO-Tagesausblick haben Sie die wichtigsten Termine im Blick und starten bestens vorbereitet in den neuen Handelstag Enthaltene Werte: DE0006602006... ► Artikel lesen | |
| CSPC PHARMA | 0,959 | -1,81 % | Dividendenbekanntmachungen (10.11.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) AGNC INVESTMENT CORP US00123Q1040 0,12 USD EUR AMBRA SA PLAMBRA00013 1,1 PLN EUR AMERICA MOVIL SAB DE CV MX01AM050019 0,27... ► Artikel lesen | |
| SELLAS LIFE SCIENCES | 7,700 | +2,67 % | Sellas Life Sciences Group: Regal erreicht die nächste Marke - was folgt jetzt? | ||
| MADRIGAL PHARMACEUTICALS | 387,40 | -0,08 % | Madrigal reports real-world data on liver disease drug Rezdiffra | ||
| ACADIA PHARMACEUTICALS | 16,410 | +0,24 % | RBC raises Acadia Pharmaceuticals stock price target on Daybue growth | ||
| CATALYST PHARMACEUTICALS | 27,300 | +2,63 % | Angelini Pharma Completes Acquisition of Catalyst Pharmaceuticals | The Italian pharma company grows its presence in the U.S. market and strengthens its global leadership in Brain Health and Rare DiseasesCompletion of the transaction gives Angelini Pharma ownership... ► Artikel lesen | |
| OPUS GENETICS | 3,780 | -1,05 % | Opus Genetics GAAP EPS of -$0.46 misses by $0.31, revenue of $1.14M misses by $0.94M | ||
| SAVARA | 4,734 | +7,30 % | Savara Inc.: Savara Announces Encore Presentations of Results from the Phase 3 Clinical Trial of Molgramostim Inhalation Solution (Molgramostim) in Autoimmune Pulmonary Alveolar Proteinosis (APAP) at the European Respiratory Society (ERS) Congress 2026 | -- Company to Host Industry Evening Mini-Symposium on aPAP with Renowned Key Opinion Leaders --Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases... ► Artikel lesen | |
| ELITE PHARMACEUTICALS | - | - | Elite Pharmaceuticals, Inc.: Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Second Quarter of Fiscal Year 2027 Financial Results on November 13, 2026 | Financials for Second Quarter of Fiscal Year 2027 Ended September 30, 2026 will be released on Thursday, November 12, 2026Northvale, New Jersey--(Newsfile Corp. - November 10, 2026) - Elite Pharmaceuticals... ► Artikel lesen | |
| GALECTIN THERAPEUTICS | 2,680 | -11,84 % | Galectin Therapeutics to present NASH cirrhosis trial data at AASLD | ||
| BIODEXA PHARMACEUTICALS | 1,710 | +0,59 % | Biodexa reports progress on FAP and GIST drug trials | ||
| NEURIZON THERAPEUTICS | 0,029 | -3,33 % | NEURIZON THERAPEUTICS LIMITED: Change in substantial holding | ||
| CIPHER PHARMACEUTICALS | 8,600 | 0,00 % | Cipher Pharmaceuticals Schedules Q3 2026 Earnings Release and Conference Call | ||
| ACURA PHARMACEUTICALS | - | - | ACURA PHARMACEUTICALS, INC - NT 10-Q, Notification of inability to timely file Form 10-Q or 10-QSB | ||
| VASO | - | - | Vaso Corporation Announces Financial Results for Second Quarter of 2026 | PLAINVIEW, N.Y., Aug. 14, 2026 (GLOBE NEWSWIRE) -- Vaso Corporation ("Vaso") (OTCQX: VASO), a leading MedTech company with a business portfolio in professional sales services and proprietary non-invasive... ► Artikel lesen |